Oprazium (Omeprazole)

Omeprazole, the active ingredient in Oprazium, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Oprazium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oprazium is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief in several acid‑related disorders. - Gastro‑oesophageal reflux disease: Improves symptoms and promotes healing of the esophageal lining. - Peptic ulcer disease: Facilitates ulcer healing and reduces recurrence. - Zollinger‑Ellishon syndrome: Controls excessive gastric acid production associated with this rare condition.

Adverse reactions to Oprazium are generally mild to moderate and vary with individual sensitivity.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Clostridioides difficile‑associated colitis - Low magnesium levels (hypomagnesemia) - Bone fractures, especially with long‑term use - Liver enzyme abnormalities - Acute interstitial nephritis

When prescribing Oprazium, clinicians should consider several safety aspects. - Assess renal/if  :   - Assess      :   - Review         ":[  ].  "); -  ");   "  " "  " " " " " " " " " " …  " ",